COVID-19 Partnering Deals Collection (Bimonthly Updates): Deal Trends, Financials and Players
BioNTech SE - American Depositary Shares (BNTX)
Company Research
Source: PR Newswire
DUBLIN, April 16, 2020 /PRNewswire/ -- The "Global COVID-19 Partnering - 12 month subscription" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Partneringprovides the full collection of COVID-19 disease deals signed between the world's pharmaceutical and biotechnology companies since the start of 2020. This fast moving dealmaking report is updated twice monthly and sent to you by email over the 12 month subscription.Trends in COVID-19 partnering deals Financial deal terms for headline, upfront and royalty by stage of development COVID-19 partnering agreement structure COVID-19 partnering contract documents Top COVID-19 deals by value Most active COVID-19 dealmakersThe report takes readers through the comprehensive COVID-19 disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering COVID-19 deals.The report presents financial deal terms values for COVID-19 deals, where avai
Show less
Read more
Impact Snapshot
Event Time:
BNTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTX alerts
High impacting BioNTech SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BNTX
News
- 2 Healthcare Stocks to Buy and 1 to Approach With Caution [Yahoo! Finance]Yahoo! Finance
- BioNTech (BNTX) had its "buy" rating reaffirmed by Berenberg Bank.MarketBeat
- BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial CancerGlobeNewswire
- BioNTech (BNTX) had its price target raised by Morgan Stanley from $125.00 to $126.00. They now have an "overweight" rating on the stock.MarketBeat
- BioNTech (BNTX) had its "sell (d-)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
BNTX
Earnings
- 3/10/26 - Beat
BNTX
Sec Filings
- 4/13/26 - Form 3/A
- 4/13/26 - Form 6-K
- 4/2/26 - Form 6-K
- BNTX's page on the SEC website